Taiwan Medical Device Registration

Unlock the Taiwanese market with expert regulatory guidance, quality system oversight, and an independent Taiwan agent, with Cisema.

We help foreign manufacturers of Taiwan medical devices and IVDs in Taiwan successfully register their products with the Taiwan Food and Drug Administration (TFDA), meet all documentation and quality system documentation requirements, and maintain compliance across the device lifecycle. As your Taiwan Registration Holder (TRH), we manage your Taiwan medical device registration process from initial classification strategy through post-market surveillance.

With a presence in Taipei and a deep understanding of Taiwan’s Medical Devices Act, Cisema acts as your trusted in country regulatory representative. We provide complete support for device classification, technical reviews, quality system documentation QSD, and registration submission for Class I, Class II, and III devices.

Whether registering a new product, seeking amendments to your medical device permit license, or managing post-market obligations, Cisema gives you clarity, speed, and control.

From risk assessment and QMS alignment to TFDA application support and labeling compliance, we simplify your path to market. We also assist with documentation aligned to the Good Manufacturing Practice requirements and ISO 13485, ensuring conformity with Taiwan medical device expectations.

Taiwan Medical Device Registration
Medical Device Registration in Taiwan

Service for IVD & Medical Device Registration in Taiwan

Cisema’s team manages your full device registration in Taiwan, aligning with the Taiwan Food and Drug Administration authority’s requirements and supporting a seamless market entry.

Regulatory Strategy & Classification

Classify your Taiwan medical device or IVD under Taiwan’s risk-based framework (Class I, Class II, or Class III)
Determine whether fast-track or pre market approval based on reference countries is applicable
Define the most effective regulatory pathway according to your primary intended actions

Quality System Documentation (QSD) Registration

Before submitting your product registration application to TFDA, most manufacturers must obtain a Quality System Documentation (QSD) certificate. This mandatory step verifies your compliance with ISO 13485 or an equivalent quality management system. We guide you in preparing and submitting your full QSD application and managing all interactions with TFDA until your certificate is issued.

QSD is required for all Class II and III devices, and many Class I products
Some Class I non-sterile, non-measuring devices may be exempt
QSD approval is performed as a remote, paper-based review by the Taiwan Food and Drug authority
Documentation includes ISO 13485 certificate, SOPs, quality manual and facility details
QSD and product registration can be submitted in parallel, but TFDA will issue the medical device permit license only after QSD approval
Typical QSD review time is around 6 months and the certificate is valid for 3 years.

Registration Application & TFDA Submission

Submit through the TFDA e-Portal and manage all administrative and technical reviews
Act as your regulatory contact for communication with the TFDA
Localize Instructions for Use (IFU), packaging, and labeling to meet Taiwan Food and Drug Administration standards
Coordinate submission fees and respond to authority feedback throughout the pre market approval process.

Post-Approval Services

Handle renewals, reclassification, and amendments to the medical device permit license
Manage adverse event reporting, serious adverse event follow-up, and Field Safety Corrective Actions (FSCA) coordination.

Taiwan Agent & Taiwan Registration Holder Services

Foreign manufacturers must appoint a Taiwan agent or in country regulatory representative as the legal license holder to register with the Taiwan Food and Drug Administration. Cisema acts as your compliant TRH, fulfilling all regulatory duties transparently.

What we do:

Serve as your legal license holder for all Taiwan medical device, IVD and combined product registrations
Submit and maintain your product license with TFDA
Issue Letters of Authorization to your preferred importers and distributors
Enable flexibility in changing distributors without re-registration
Monitor post-market updates and ensure ensuring compliance with the Medical Devices Act
Manage direct prevention actions like FSCA and recalls
Maintain your quality system, and support audits and inspections tied to ISO 13485

Quality Control Inspection Services in Taiwan

Cisema also provides tailored inspection services for Taiwan medical devices and IVDs to ensure compliance with local and international standards.

Incoming Goods Inspections

Verify packaging, labeling, and shipping conditions upon arrival
Review documentation including invoices, certifications, and declarations of conformity
Confirm product readiness for the Taiwanese market

In-Process Quality Monitoring

Inspect during repackaging or relabeling for hygiene, SOPs, and quality system control
Validate traceability and batch consistency

Final Product Release Inspections

Conduct AQL sampling and performance checks
Ensure conformity of labeling and IFU with Taiwanese regulatory requirements

Special Inspection Projects

Support Good Manufacturing Practice audits and TFDA site inspections
Collaborate with third-party bodies for tailored compliance audits
Conduct serial number validation and corrective action reviews.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

How China IVD Risk Classification Determines Your NMPA Registration Pathway

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

July 13, 2026
How China IVD Risk Classification Determines Your NMPA Registration Pathway

A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understand South Korea’s medical device regulations, from classification to approval and post-market compliance.

July 10, 2026
A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management

Learn how MFDS’s Digital Medical Product Safety Management Roadmap will shape future compliance requirements for digital medical products in Korea.

July 10, 2026
Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management
Stock photo of a Korean man in his early 30s sitting comfortably in a bright, contemporary apartment in South Korea, casually reviewing a health monitoring app on his smartphone while wearing a small continuous glucose monitor (CGM) sensor on his arm.

What Is the MFDS? Understanding South Korea’s Medical Device Authority

Learn how South Korea’s Ministry of Food and Drug Safety regulates medical devices, including classification, application review and post-market duties.

July 10, 2026
What Is the MFDS? Understanding South Korea’s Medical Device Authority

Explained: South Korea Medical Device Classification (Class I, II, III, & IV)

Learn how South Korea medical device classification works under the MFDS.

July 10, 2026
Explained: South Korea Medical Device Classification (Class I, II, III, & IV)
Stock photo of an adult South Korean patient wearing a continuous glucose monitor (CGM) on the upper arm during a routine appointment in a modern hospital outpatient clinic

China NMPA Fee Catalogue for Drugs & Medical Devices

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.

July 10, 2026
China NMPA Fee Catalogue for Drugs & Medical Devices
Previous
Previous

Other Markets We Support for Medical Device & IVD Registration

In addition to Taiwan, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Vietnam

Philippines

Indonesia

Thailand

South Korea

Latest Insights

View More

China Expands MRI Registration Requirements Under New 2026 Review Guideline

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

July 16, 2026
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Chinese male MRI technician in a clinical, sterile medical imaging room. The man has a warm, focused expression and is wearing a dark blue medical-style t-shirt

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

July 15, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

July 14, 2026
China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

TFDA Simplifies Drug Clinical Trial Application Requirements Effective July 2026

Taiwan's TFDA will reduce clinical trial submission documents and ease decentralized trial requirements for sponsors from July 1, 2026.

June 30, 2026
TFDA Simplifies Drug Clinical Trial Application Requirements Effective July 2026
Stock photograph inside a bright, modern hospital clinical research consultation room in Taiwan. A Taiwanese clinical research physician in a white lab coat sits across from a Taiwanese adult trial participant.

Taiwan Proposes New Online Drug Enforcement Obligations Under Pharmaceutical Affairs Act

New rules expand platform accountability and regulatory oversight, reshaping how pharmaceutical products are promoted, sold, and controlled online.

June 29, 2026
Taiwan Proposes New Online Drug Enforcement Obligations Under Pharmaceutical Affairs Act

Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

July 2, 2026
Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration
A clinical trial in Hainan, China, inside a clinical research consultation room at a  hospital. A Chinese doctor in a white lab coat seated across from an adult study participant discussing routine trial procedures, a second researcher reviewing data.
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device in Taiwan.

Request Proposal